Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of ...

In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...

DUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...

British pharma major AstraZeneca (LSE: AZN) is stepping up its China strategy with plans to build a commercial cell therapy manufacturing and supply base in Shanghai, alongside a new innovation center ...

For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a ...

The MarketWatch News Department was not involved in the creation of this content. - TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of ...

WASHINGTON, DC (ANI) – U.S. lawmakers and industry leaders are intensifying calls for stricter export controls to prevent American biopharmaceutical companies from collaborating with China military on ...

Earlier this week, the congressionally-mandated National Security Commission on Emerging Biotechnology released its major report, titled “Charting the Future of Biotechnology.” The bipartisan and ...

India’s bioeconomy has expanded from about USD 10 billion in 2014 to more than USD 195 billion in 2025, reflecting a massive growth trajectory over the past decade, Union Minister Jitendra Singh said ...

New faculty-designed case is academic centerpiece for Biotech & Healthcare contest, which marks its fifth year by attracting scholars from top schools worldwide 12/10/2008 - Business students from ...

- Company also reports a key milestone of Adjusted EBITDA 1 positive operations in Q3 2025 and expects to achieve strong additional profitability growth in Q1 and Q2 2026 through continued strong ...